Aptus Capital Advisors LLC Buys Shares of 3,889 Colgate-Palmolive (NYSE:CL)

Aptus Capital Advisors LLC purchased a new stake in shares of Colgate-Palmolive (NYSE:CLFree Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,889 shares of the company’s stock, valued at approximately $277,000.

A number of other large investors have also made changes to their positions in the company. Wade G W & Inc. grew its position in Colgate-Palmolive by 5.5% during the third quarter. Wade G W & Inc. now owns 32,797 shares of the company’s stock valued at $2,332,000 after purchasing an additional 1,700 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $141,000. Pathstone Family Office LLC grew its position in Colgate-Palmolive by 93.6% during the third quarter. Pathstone Family Office LLC now owns 54,108 shares of the company’s stock valued at $3,893,000 after purchasing an additional 26,162 shares in the last quarter. Kennon Green & Company LLC grew its position in Colgate-Palmolive by 1.8% during the third quarter. Kennon Green & Company LLC now owns 14,660 shares of the company’s stock valued at $1,042,000 after purchasing an additional 262 shares in the last quarter. Finally, Platform Technology Partners grew its position in Colgate-Palmolive by 7.9% during the third quarter. Platform Technology Partners now owns 12,681 shares of the company’s stock valued at $902,000 after purchasing an additional 930 shares in the last quarter. Institutional investors and hedge funds own 78.36% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the sale, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jennifer Daniels sold 3,800 shares of the firm’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $79.01, for a total transaction of $300,238.00. Following the completion of the sale, the insider now owns 58,193 shares of the company’s stock, valued at approximately $4,597,828.93. The disclosure for this sale can be found here. In the last quarter, insiders have sold 92,123 shares of company stock valued at $7,635,941. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Price Performance

NYSE:CL opened at $83.46 on Monday. Colgate-Palmolive has a one year low of $67.62 and a one year high of $86.14. The stock has a market cap of $68.72 billion, a P/E ratio of 30.02, a PEG ratio of 3.67 and a beta of 0.42. The company has a debt-to-equity ratio of 21.40, a current ratio of 0.41 and a quick ratio of 0.26. The company has a fifty day moving average price of $80.38 and a 200 day moving average price of $76.28.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter in the prior year, the company posted $0.77 EPS. The business’s revenue was up 6.9% on a year-over-year basis. Analysts anticipate that Colgate-Palmolive will post 3.48 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Monday, January 22nd will be issued a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 2.30%. The ex-dividend date is Friday, January 19th. Colgate-Palmolive’s payout ratio is 69.06%.

Analyst Ratings Changes

CL has been the topic of a number of research analyst reports. Barclays boosted their price objective on shares of Colgate-Palmolive from $75.00 to $82.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 16th. Bank of America raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 target price for the company in a research report on Friday, December 15th. Royal Bank of Canada boosted their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Monday, October 30th. Wells Fargo & Company boosted their target price on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Monday, January 29th. Finally, Stifel Nicolaus raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and decreased their target price for the stock from $85.00 to $81.00 in a research report on Monday, October 16th. Three analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $86.93.

Check Out Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.